Member Info for HelloSanDiego

WelshFalcon - "Why was a trial needed for Covid?"

So that they know whether or not it works for Covid.

WelshFalcon - "Keep the trial playing field clear for more promising treatments."

How can you be sure Aspirin isn't one of the more positive treatments without a trial? Come to think of it, how can you even be sure it doesn't have a detrimental effect?

persimmon - "Fauci dismissed that claim as nonsense but is now having to backtrack as more and more revelations are starting to appear about flu type illness at the Wuhan Lab."

You're wrong on both counts.

What he said in May 2020 is considerably different from what you seem to believe:

"Everything about the stepwise evolution over time strongly indicates that [this virus] evolved in nature and then jumped species"

https://www.nationalgeographic.com/science/article/anthony-fauci-no-scientific-evidence-the-coronavirus-was-made-in-a-chinese-lab-cvd

The only investors here are the ones who put their money in before the NDA was turned down and I sympathize with them. The rest of us just placed a high-risk bet in the hope of a high-return.

For anyone who wasn't aware, Warren Buffett took over Berkshire Hathaway as an RTO. He offered them $11.50 per share. It's taken 60 years but each share is worth $439,000 today.

Between the posters on here we probably own about 2% of the company. It's really not worth trying to influence anyone's vote. I'm not creating doubt. I'm pointing it out for the benefit of those who haven't worked it out for themselves.

RosieNas: "We will still be entitled to any gain. Our shareholdings will still exist. That's the law in my understanding."

That's my understanding, too. But I think there's pretty much no chance we would ever see any of it.

I think it's more likely the BoD would then be able to carve it up among themselves if the company delists. In that case we'd end up with nothing and they would be even better off than it's we'd all voted 'yes'.

Any experts here want to offer their opinion?

Rosie, if the company has effectively shut down in the meantime because there's no money for rent and administrative costs, how do you imagine that money would make its way to shareholders' bank accounts?

My guess is, it won't. But I'm happy to consider other opinions.

McFish2020: "So what are the issues that aren’t being discussed??"

I mentioned two of them in the post you just replied to.

Is it possible the BoD are counting on us to reject the RTO so that they can divide the company's assets up among themselves once it's delisted?

There are a lot of issues that nobody here is even considering. I mean, if we've got a large enough stake to decide the outcome of the vote, we've obviously got a lot more to lose than the board have.

Can you give us any idea when we can expect an official update on what's happening, particularly with the breathalyser?

Weeks? Months?

These shares sat at a tenth of a penny for a long time prior to last May. So anyone who invested then is getting a fair deal.

Those of us who jumped on the bandwagon while the price rose ten-fold are the only ones who are losing out, and we all knew it was high risk in the hopes of high reward. The bright side is, if we accept the RTO and let them get on with their more important work they might actually solve some real problems (e.g. cancer).

So far I've counted five shrewd investors on here willing to vote against themselves receiving any possible return on their investment.

Does anybody know what we would achieve by voting against the RTO?

I haven't seen any mention of that here.

Have I misread this or are they effectively letting Motif Bio and its assets go for £600k even though an empty cash shell alone is worth £350k?

"Clinigen ? Long forgotten. Contributed nothing."

Are you sure about that?

Clinigen specializes in getting one-off treatments delivered to the hospitals that need them. Maybe that's what they were really brought in to do. Do we know how the drug is being distributed for the trial or do we think they just put it in a postbox and cross their fingers?

It's still available on Google cache. I don't know how often it updates though.

https://webcache.googleusercontent.com/search?q=cache:JC0woLpfCg8J:https://www.lse.co.uk/ShareChat.asp%3FShareTicker%3DSNG%26share%3DSynairgen+&cd=2&hl=en&ct=clnk&gl=uk

I'm not sure about Polar specifically, but the British IIs tend to issue TR1s immediately.

Not only that, but everything in Friday's RNS would have been anticipated well in advance. The only 'bad' news was that the sample was too small to prove statistical significance, which we knew long before the results were in just by looking at the trial setup. So if an II wanted to offload some of their stake I think they would have done it gradually throughout the last week instead of triggering a steep drop.

No, I think it was PIs who expected the price to good through the roof at the next hint of good news. And when it didn't they panicked and sold up.

I could be wrong but this looks like the vaccine panic all over again. That was the only thing that took the share price to 77p last December.

60p. I initially bought in at 70p but the share price dropped to 35p for no good reason a few weeks later, so I thought it was worth buying more.

Has anyone identified what was said 10 minutes into yesterday's presentation that triggered the steep drop?

I'm happy with the way this is progressing.

We went from hearing nothing for months to finding out they had identified a decent number of prospects, then entered into negotiations with a few of them and are now completing an RTO with one. And it's with a company that develops antibody drug conjugates. That's literally the best kind of conjugates.